Evaluation of age and sex differences in locomotion and catalepsy during repeated administration of haloperidol and clozapine in adolescent and adult rats

Pharmacological Research

Volumn 58, Issue 3-4, 2008, Pages 240-246

  Wiley, Jenny L ^a   Evans, Rhys L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Adolescent; Antipsychotics; Catalepsy; Clozapine; Haloperidol; Locomotion; Sex differences

Indexed keywords

CLOZAPINE; HALOPERIDOL;

ADOLESCENT; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; LOCOMOTION; MALE; MOTOR PERFORMANCE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

AGING; ANIMALS; ANTIPSYCHOTIC AGENTS; CATALEPSY; CLOZAPINE; DYSKINESIA, DRUG-INDUCED; FEMALE; HALOPERIDOL; MALE; MOTOR ACTIVITY; RATS; RATS, LONG-EVANS; SEX CHARACTERISTICS;

EID: 54349089567     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2008.08.002     Document Type: Article

References (35)

1. Greenhill L.L., and Setterberg S. Pharmacotherapy of disorders of adolescents. Psychiatr Clin N Am 16 (1993) 793-814
2. Sylvester C. Psychopharmacology of disorders in children. Psychiatr Clin N Am 16 (1993) 779-791
3. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24 4 (2000) 417-463
4. McQuade R.D., Duffy R.A., Coffin V.L., and Barnett A. In vivo binding to dopamine receptors: a correlate of potential antipsychotic activity. Eur J Pharmacol 215 1 (1992) 29-34
5. Schotte A., Janssen P.F., Gommeren W., Luyten W.H., Van Gompel P., Lesage A.S., et al. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 124 1/2 (1996) 57-73
6. Wiley J.L., and Martin B.R. Cannabinoid pharmacological properties common to other centrally acting drugs. Eur J Pharmacol 471 3 (2003) 185-193
7. National Research Council. Guide for the care and use of laboratory animals (1996), National Academy Press, Washington, DC
8. Simon V.M., Parra A., Minarro J., Arenas M.C., Vinader-Caerols C., and Aguilar M.A. Predicting how equipotent doses of chlorpromazine, haloperidol, sulpiride, raclopride and clozapine reduce locomotor activity in mice. Eur Neuropsychopharmacol 10 3 (2000) 159-164
9. Bardin L., Kleven M.S., Barret-Grevoz C., Depoortere R., and Newman-Tancredi A. Antipsychotic-like vs. cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties. Neuropsychopharmacology 31 9 (2006) 1869-1879
10. Cuomo V., Cagiano R., Coen E., Mocchetti I., Cattabeni F., and Racagni G. Enduring behavioural and biochemical effects in the adult rat after prolonged postnatal administration of haloperidol. Psychopharmacology (Berl) 74 2 (1981) 166-169
11. Shalaby I.A., and Spear L.P. Chronic administration of haloperidol during development: later psychopharmacological responses to apomorphine and arecoline. Pharmacol Biochem Behav 13 5 (1980) 685-690
12. Cuomo V., Cagiano R., Mocchetti I., Coen E., Cattabeni F., and Racagni G. Behavioural and biochemical effects in the adult rat after prolonged postnatal administration of clozapine. Psychopharmacology (Berl) 81 3 (1983) 239-243
13. Campbell A., and Baldessarini R.J. Effects of maturation and aging on behavioral responses to haloperidol in the rat. Psychopharmacology (Berl) 73 3 (1981) 219-222
14. Campbell A., Baldessarini R.J., and Teicher M.H. Decreasing sensitivity to neuroleptic agents in developing rats; evidence for a pharmacodynamic factor. Psychopharmacology (Berl) 94 1 (1988) 46-51
15. Weihmuller F.B., and Bruno J.P. Age-dependent plasticity in the dopaminergic control of sensorimotor development. Behav Brain Res 35 2 (1989) 95-109
16. Spear L.P., Shalaby I.A., and Brick J. Chronic administration of haloperidol during development: behavioral and psychopharmacological effects. Psychopharmacology (Berl) 70 1 (1980) 47-58
17. Brunell S.C., and Spear L.P. Effects of acute ethanol or amphetamine administration on the acoustic startle response and prepulse inhibition in adolescent and adult rats. Psychopharmacology (Berl) 186 4 (2006) 579-586
18. Collins S.L., and Izenwasser S. Cocaine differentially alters behavior and neurochemistry in periadolescent versus adult rats. Brain Res Dev Brain Res 138 1 (2002) 27-34
19. Aberg M., Wade D., Wall E., and Izenwasser S. Effect of MDMA (ecstasy) on activity and cocaine conditioned place preference in adult and adolescent rats. Neurotoxicol Teratol 29 1 (2007) 37-46
20. Campbell A., Baldessarini R.J., and Cremens M.C. Dose-catalepsy response to haloperidol in rat: effects of strain and sex. Neuropharmacology 27 11 (1988) 1197-1199
21. Sanberg P.R., Pevsner J., and Coyle J.T. Parametric influences on catalepsy. Psychopharmacology 82 (1984) 406-408
22. Steinpreis R.E., and Salamone J.D. Effects of acute haloperidol and reserpine administration on vacuous jaw movements in three different age groups of rats. Pharmacol Biochem Behav 46 2 (1993) 405-409
23. Pizzolato G., Soncrant T.T., Holloway H.W., and Rapoport S.I. Reduced metabolic response of the aged rat brain to haloperidol. J Neurosci 5 11 (1985) 2831-2838
24. Buchsbaum M.S., Haznedar M.M., Aronowitz J., Brickman A.M., Newmark R.E., Bloom R., et al. FDG-PET in never-previously medicated psychotic adolescents treated with olanzapine or haloperidol. Schizophr Res 94 1-3 (2007) 293-305
25. Seeman P. Atypical antipsychotics: mechanism of action. Can J Psychiatry 47 1 (2002) 27-38
26. Huang N., Ase A.R., Hebert C., van Gelder N.M., and Reader T.A. Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: homogenate binding and autoradiographic studies. Neurochem Int 30 3 (1997) 277-290
27. Damask S.P., Bovenkerk K.A., de la Pena G., Hoversten K.M., Peters D.B., Valentine A.M., et al. Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex. Brain Res Mol Brain Res 41 1-2 (1996) 241-249
28. Zhang W., and Bymaster F.P. The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors. Psychopharmacology (Berl) 141 3 (1999) 267-278
29. Miller J.C. Sex differences in dopaminergic and cholinergic activity and function in the nigro-striatal system of the rat. Psychoneuroendocrinology 8 2 (1983) 225-236
30. Hafner H., Behrens S., De Vry J., and Gattaz W.F. An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia. Psychiatry Res 38 2 (1991) 125-134
31. Zhou W., Cunningham K.A., and Thomas M.L. Estrogen regulation of gene expression in the brain: a possible mechanism altering the response to psychostimulants in female rats. Brain Res Mol Brain Res 100 1-2 (2002) 75-83
32. Fink G., Sumner B.E., Rosie R., Grace O., and Quinn J.P. Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol 16 3 (1996) 325-344
33. Andersen S.L., Thompson A.P., Krenzel E., and Teicher M.H. Pubertal changes in gonadal hormones do not underlie adolescent dopamine receptor overproduction. Psychoneuroendocrinology 27 6 (2002) 683-691
34. Andersen S.L., Rutstein M., Benzo J.M., Hostetter J.C., and Teicher M.H. Sex differences in dopamine receptor overproduction and elimination. Neuroreport 8 6 (1997) 1495-1498
35. Valencia-Sanchez A., Esparza-Avalos N.S., Cruz M.L., and Ortega-Corona B.G. Amine neurotransmitter levels in male and female rats through developmental periods. Arch Androl 39 1 (1997) 79-83